T1	Participants 129 154	nasopharyngeal carcinoma.
T2	Participants 560 710	retrospectively reviewed 749 patients who underwent MRI and were subsequently histologically diagnosed with nondisseminated NPC and treated with IMRT.
T3	Participants 1520 1549	prognostic factor in patients
T4	Participants 1651 1657	value.
T5	Participants 1658 1709	Therefore, patients with various subclassifications
